Economic Competition

• 

  Subject Areas on Research

  • A survey of beliefs about managed care. 
  • Adverse selection: does it preclude a competitive health insurance market? 
  • An Organizational Field Approach to Resource Environments in Healthcare: Comparing Entries of Hospitals and Home Health Agencies in the San Francisco Bay Region 
  • Antitrust and hospital peer review. 
  • Arrow's concept of the health care consumer: a forty-year retrospective. 
  • Association of Hospital Market Concentration With Costs of Complex Hepatopancreaticobiliary Surgery. 
  • Certificate-of-need in an antitrust context. 
  • Commercialism in nonprofit hospitals. 
  • Competition among physicians, revisited. 
  • Competition between non-profit and for-profit health insurers. 
  • Defining geographic markets for hospital care. 
  • Does generic entry always increase consumer welfare? 
  • Does reimportation reduce price differences for prescription drugs? Lessons from the European Union. 
  • Does removing certificate-of-need regulations lead to a surge in health care spending? 
  • Effect of Regional Hospital Market Competition on Use Patterns of Free Flap Breast Reconstruction. 
  • Effects of competition among fertility centers on pregnancy and high-order multiple gestation rates. 
  • Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act. 
  • Hierarchical cognitive control deficits following damage to the human frontal lobe. 
  • Hospital cost shifting. 
  • Impacts of the Master Settlement Agreement on the tobacco industry. 
  • Industrialized health care and midcareer crises. 
  • Market-Based Solutions to Antitrust Threats-- The Rejection of the Partners Settlement 
  • Multiple prior years of health expenditures and Medicare health plan choice. 
  • Options to Promote Competitive Generics Markets in the United States. 
  • Perverse incentives in the Medicare prescription drug benefit. 
  • Quality assessment in contracting for tertiary care services by HMOs: a case study of three markets. 
  • Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future. 
  • Risk and markets for ecosystem services. 
  • Talk the game, then play the game. 
  • The Biomarkers Consortium: practice and pitfalls of open-source precompetitive collaboration. 
  • The Commercial Market For Priority Review Vouchers. 
  • The impact of specialty pharmaceuticals as drivers of health care costs. 
  • The profit motive in medicine. 
  • The role of community values in setting healthcare priorities. Ethically and financially viable, or merely a "modest proposal?". 
  • Using the laboratory information system to achieve strategic advantage over the competitors of hospital-based clinical laboratories. 
  • Variation in markup of general surgical procedures by hospital market concentration. 
  • Walk-in clinics in Ontario. An atmosphere of tension. 
  • What is a free customer worth? Armchair calculations of nonpaying customers' value can lead to flawed strategies. 
• 

  Keywords of People

  • Attarian, David Edward, Professor of Orthopaedic Surgery, Orthopaedics